Page 4 - Oncogenex Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncogenex pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncogenex Pharmaceuticals Today - Breaking & Trending Today

World Cancer Gene Therapy Market Industry Forecasts to 2030

World Cancer Gene Therapy Market Industry Forecasts to 2030
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Cancer Gene Therapy Market was valued at USD 558.24 million in 2019 and is estimated to reach USD 16.50 billion by 2030, expanding at a CAGR of 32.6% during the forecast period, from 2020 to 2030
Gene therapy is a method of replacing or inactivating the mutated genes responsible for causing diseases or the genes that affect the proper functioning of organs, by introducing a new gene into the body. The adoption of cancer gene therapy is rising due to its high success rate achieved during trials. Cancer gene therapy is used as a substitute of the conventional drugs and surgeries to treat cancer. It has several advantages including high efficacy, minimum side effects and speedy recovery. ....

United States , Sibiono Genetech , Laura Wood , Custom Research , Office Hours Call , World Health Organization , Drug Administration , Porter Five Force Model Analysis , Company Profiles , E St Office Hours Call , Oncogenex Pharmaceuticals , Gene Therapy Market , Opportunity Analysis , Industry Forecast , Global Cancer Gene Therapy Market , North America , Anchiano Therapeutics , Shenzhen Sibiono Genetech , Synergene Therapeutics , Shanghai Sunway Biotech , New Drug Application , Topics Covered , Five Force Model , Cancer Gene Therapy Market , Senior Manager , Free Call ,

Global Antisense & RNAi Therapeutics Market Report 2020-2030 with COVID-19 Growth and Change Impact Insights

Share this article
Share this article
ResearchAndMarkets.com s offering.
Antisense & RNAi Therapeutics Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global antisense & RNAi therapeutics market.
Major players in the antisense & RNAi therapeutics market are Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Gene Signal, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Marina Biosciences, Quark Pharmaceuticals, Sanofi S.A, Acuitas Therapeutics and Antisense Therapeutics Ltd.
The global antisense & RNAi therapeutics market is expected to decline from $1.14 billion in 2019 to $1.11 billion in 2020 at a compound annual growth rate (CAGR) of -2.89%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities ....

United States , Aptose Biosciences , Cenix Bioscience , Asia Pacific , Marina Biosciences , Laura Wood , National Institute Of Environmental Health Sciences , Glaxosmithkline Plc , Olix Pharmaceuticals , Alnylam Pharmaceuticals Inc , Silence Therapeutics Plc , Benitec Biopharma Ltd , Sirnaomics Inc , Calando Pharmaceuticals , Alnylam Pharmaceuticals , Enzon Pharmaceuticals Inc , Rexahn Pharmaceuticals , Vico Therapeutics , Novartis International , Antisense Therapeutics Ltd , Oncogenex Pharmaceuticals , Rxi Pharmaceuticals , Quark Pharmaceuticals , Custom Research , Medicines Company , Office Hours Call ,

Global Antisense & RNAi Therapeutics Market Report 2020: 2019 Data and Long-term Forecast to 2023, 2025 & 2030 - ResearchAndMarkets.com - Press Release

Global Antisense & RNAi Therapeutics Market Report 2020: 2019 Data and Long-term Forecast to 2023, 2025 & 2030 - ResearchAndMarkets.com - Press Release
digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.

United States , Aptose Biosciences , Cenix Bioscience , Asia Pacific , Marina Biosciences , Laura Wood , Glaxosmithkline Plc , National Institute Of Environmental Health Sciences , Olix Pharmaceuticals , Alnylam Pharmaceuticals Inc , Silence Therapeutics Plc , Sirnaomics Inc , Benitec Biopharma Ltd , Alnylam Pharmaceuticals , Calando Pharmaceuticals , Enzon Pharmaceuticals Inc , Vico Therapeutics , Rexahn Pharmaceuticals , Novartis International , Antisense Therapeutics Ltd , Oncogenex Pharmaceuticals , Quark Pharmaceuticals , Rxi Pharmaceuticals , Medicines Company , Office Hours Call , Tekmira Pharmaceuticals ,